Z

Zai Lab Limited
D

ZLAB

33.780
USD
2.75
(8.86%)
مغلق
حجم التداول
57,619
الربح لكل سهم
-0
العائد الربحي
-
P/E
-12
حجم السوق
3,679,897,062
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ADBE
    ADBE
    -10.26
    (-2.26%)
    444.30 USD
    CRWD
    CRWD
    -29.49
    (-6.76%)
    406.64 USD
    MSFT
    MSFT
    -7.96
    (-1.91%)
    408.15 USD
    NVDA
    NVDA
    -5.850
    (-4.18%)
    134.260 USD
    O
    OKTA
    -2.450
    (-2.57%)
    92.740 USD
    PANW
    PANW
    -7.720
    (-3.88%)
    191.080 USD
    TEAM
    TEAM
    -12.38
    (-4.15%)
    286.04 USD
    V
    VEEV
    -2.960
    (-1.29%)
    225.900 USD
    المزيد
الأخبار
المقالات

العنوان: Zai Lab Limited

القطاع: Healthcare
الصناعة: Biotechnology
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.